Biogen lays off staffers at newly acquired Reata, with 113 set to lose positions

That didn't take long.

Just two weeks after Biogen completed its buyout of Reata Pharmaceuticals, the combined company is trimming its staff.

In a recent Worker Adjustment and Retraining Notification (WARN) notice sent to state officials in Texas, Reata said it's cutting 113 positions. The layoffs will take effect late next month.